DRAK1 (N-Terminus) antibody

Serine/threonine-protein kinase 17A
DAP kinase-related apoptosis-inducing protein kinase 1
Gene name: STK17A, DRAK1
As low as $645.70
In stock
Ref
00097830
Certain serine/threonine protein kinases, such as ASK-1 and RIP, are mediators of apoptosis.
Two novel serine/threonine kinases that induce apoptosis have been identified and designated DRAK1 and DRAK2 for DAP kinase–related apoptosis-inducing protein kinases. DRAKs contain an N-terminal kinase domain and a C-terminal regulation domain. Overexpression of DRAK1 induces apoptosis. DRAKs have high sequence homology to DAP and ZIP kinases, and they represent a novel family of serine/threonine kinases which mediate apoptosis through their catalytic activities. DRAK1 is located in cell nuclei, and the mRNA for DRAK1 is ubiquitously expressed in human tissues.
More Information
ID Covalab pab60124
Product type Primary antibodies
Clonality Polyclonal antibody
Raised in Rabbit
Immunogen Peptide corresponding to N-terminus part (aa 5-19) of human DRAK1.
Activity cross reaction Reacts with human DRAK1. No cross-reactivity with DRAK2, DAP or ZIP kinases.
Species Hu
Labelling None
Form Purified
Preservative NaN3 0.02%
Storage instructions Stable for at least one year at -20°C. Avoid multiple freeze-thaw cycles.
Target DRAK1
Uniprot ID Q9UEE5
Gene ID 9263
Applications ICC, WB
Working dilutions Optimal dilution should be determined by the end user.
The following are guidelines only:
ICC (2 µg/ml)
WB (1 µg/ml)
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account